Formalin-fixed Staphylococcus aureus particles prevent allergic sensitization in a murine model of type I allergy

International Archives of Allergy and Immunology

Volumn 144, Issue 3, 2007, Pages 183-196

  Gisch, Karina ^a   Gehrke, Nadine ^a   Bros, Matthias ^a   Priesmeyer, Christina ^a   Knop, Jürgen ^a   Reske Kunz, Angelika B ^a   Sudowe, Stephan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Allergic airway inflammation, experimental; Bone marrow derived dendritic cells; Hygiene hypothesis; IgE; Immune deviation; Mouse model of type I allergy; Protein A; Staphylococcus aureus

Indexed keywords

ALLERGEN; FORMALDEHYDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 12P35; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PROBIOTIC AGENT; PROTEIN A; PROTEIN P40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENSITIZATION; STAPHYLOCOCCUS AUREUS;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FIXATIVES; FORMALDEHYDE; HYPERSENSITIVITY; IMMUNIZATION; MICE; MICE, INBRED BALB C; PARTICULATE MATTER; STAPHYLOCOCCUS AUREUS;

EID: 35348925453     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103991     Document Type: Article

References (63)

1. Jarvis D, Burney P: ABC of allergies. The epidemiology of allergic disease. BMJ 1998; 316:607-610.
2. Strachan DP: Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax 2000;55:S2-S10.
3. Liu AH, Murphy JR: Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol 2003;111:471-478.
4. Shirakawa T, Enomoto T, Shimazu S, Hopkin J: The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-79.
5. Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, Stroffolini T, Pasquini P, D'Amelio R: Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997;314:999-1003.
6. Maizels RM: Infection and allery - helminths, hygiene and host immune regulation. Curr Opin Immunol 2005;17:656-661.
7. Romagnani S: The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352-363.
8. Herz U, Gerhold K, Grüber C, Braun A, Wahn U, Renz H, Paul K: BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867-874.
9. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G: Infection of mice with Mycobacterium bovis -Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-569.
10. Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, Pay G, Walker C: Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 2002;169:1492-1499.
11. Smit JJ, Van Loveren H, Hoekstra MO, Schijf MA, Folkerts G, Nijkamp FP: Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin Exp Allergy 2003;33:1083-1089.
12. Hopfenspirger MT, Agrawal DK: Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168:2516-2522.
13. Hansen G, Yeung VP, Berry G, Umetsu DT, DeKruyff RH: Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J Immunol 2000;164:223-230.
14. Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA: Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003;170:3289-3295.
15. Ennis DP, Cassidy JP, Mahon BP: Prior Bordatella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin Exp Allergy 2004;34:1488-1497.
16. Kaisho TK, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979-987.
17. Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS: Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun 1994;62:4244-4249.
18. Von Mutius E, Braun-Fahrländer C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M, Nowak D: Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000;30:1230-1234.
19. Tulic MK, Wale JL, Holt PG, Sly PD: Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000;22:604-612.
20. Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, Liu AH: Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 2000;355:1680-1683.
21. Gerhold K, Blümchen K, Bock A, Franke A, Avagjan A, Hamelmann E: Endotoxins and allergy: lessons from the murine model. Pathobiology 2002-2003;70:255-259.
22. Reed CE, Milton DK: Endotoxin-stimulated innate immunity: a contributing factor for asthma. J Allergy Clin Immunol 2001;108:157-166.
23. Jappe U, Heuck D, Witte W, Gollnick H: Superantigen production by Staphylococcus aureus in atopic dermatitis: no more than a coincidence? J Invest Dermatol 1998;110:844-846.
24. Leung DY: Infection in atopic dermatitis. Curr Opin Pediatr 2003;15:399-404.
25. Zollner TM, Wichelhaus TA, Hartung A, von Mallinckrodt C, Wagner TO, Brade V, Kaufmann R: Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000;30:994-1000.
26. Bunikowski R, Mielke M, Skarabis H, Herz U, Bergmann RL, Wahn U, Renz H: Prevalence and role of serum IgE antibodies to the Staphylococcus aureus -derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999;103:119-124.
27. Wehner J, Neuber K: Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. Br J Dermatol 2001;145:302-305.
28. Breuer K, Wittmann M, Bösche B, Kapp A, Werfel T: Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000;55:551-555.
29. Dziarski R, Ulmer AJ, Gupta D: Interactions of CD14 with components of grampositive bacteria. Chem Immunol 2000;74:83-107.
30. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-17409.
31. Matsui K, Motohashi R, Nishikawa A: Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis. J Interferon Cytokine Res 2000;20:321-324.
32. Matsui K, Nishikawa A: Lipoteichoic acid from Staphylococcus aureus enhances allergen-specific immunoglobulin E production in mice. Clin Exp Allergy 2003;33:842-848.
33. Cleveland MG, Gorham JD, Murphy TL, Tuomanan E, Murphy KM: Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996;64:1906-1912.
34. Sinha P, Ghosh AK, Das T, Sa G, Ray PK: Protein A of Staphylococcus aureus evokes Th1 type responses in mice. Immunol Lett 1999;67:157-165.
35. Jarman ER, Kuba A, Montermann E, Bartlett RR, Reske-Kunz AB: Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide. Clin Exp Immunol 1999;115:221-228.
36. Sudowe S, Montermann E, Steitz J, Tüting T, Knop J, Reske-Kunz AB: Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Gene Ther 2002;9:147-156.
37. Sudowe S, Specht C, Kolbe L, Kölsch E: In situ dormancy of B lymphocytes programmed for an IgE antibody response and their sudden release from unresponsiveness under in vitro conditions. Int Immunol 1995;7:1799-1807.
38. Scheicher C, Mehlig M, Zecher R, Reske K: Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J Immunol Meth 1992;154:253-264.
39. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Meth 1999;223:77-92.
40. Becker D, Mohamadzadeh M, Reske K, Knop J: Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. J Invest Dermatol 1992;99:545-549.
41. Weigmann B, Jarman ER, Sudowe S, Bros M, Knop J, Reske-Kunz AB: Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity. J Invest Dermatol 2006;126:1524-1533.
42. Jonuleit H, Schmitt E: The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003;171:6323-6327.
43. Ziegler SF: FOXP3: of mice and men. Annu Rev Immunol 2006;24:209-226.
44. Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB: Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J Allergy Clin Immunol 2006;117:196-203.
45. Peng Z, Wang H, Mao X, HayGlass KT, Simons FE: CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice. Int Immunol 2001;13:3-11.
46. Maecker HT, Hansen G, Walter DM, De Kruyff R, Levy S, Umetsu DT: Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J Immunol 2001;166:959-965.
47. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F: Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nat Immunol 2000;1:311-316.
48. Kuipers H, Hijdra D, de Vries VC, Hammad H, Prins JB, Coyle AJ, Hoogsteden HC, Lambrecht BN: Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J Immunol 2003;171:3645-3654.
49. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002;168:2255-2263.
50. Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-146.
51. Mitsui H, Watanabe T, Saeki H, Mori K, Fujita H, Tada Y, Asahina A, Nakamura K, Tamaki K: Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol 2004;122:95-102.
52. Lawrence C, Nauciel C: Production of interleukin-12 by murine macrophages in response to peptidoglycan. Infect Immun 1998;66:4947-4949.
53. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
54. Hunter CA: New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005;5:521-531.
55. Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, Yang HY, Sahin AA, Hunt KK, Fuson KL, Poindexter N, Roth JA, Ramesh R, Grimm EA, Mhashilkar AM: MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int Immunopharmacol 2004;4:649-667.
56. Groux H: Type 1 T-regulatory cells: their roles in the control of immune responses. Transplantation 2003;75:8S-12S.
57. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-731.
58. McGuirk P, McCann C, Mills KH: Pathogenspecific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis . J Exp Med 2002;195:221-231.
59. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003;18:605-617.
60. Stock P, Akbari O, Berry G, Freeman GJ, DeKruyff RH, Umetsu DT: Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against hyper-reactivity. Nat Immunol 2004;5:1149-1156.
61. Thomson CW, Lee BP, Zhang L: Doublenegative regulatory T cells: non-conventional regulators. Immunol Res 2006;35:163-178.
62. Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V: Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 2004;53:64-72.
63. Zhang C, Zhang J, Tian Z: The regulatory effect of natural killer cells: do 'NK-reg cells' exist? Cell Mol Immunol 2006;3:241-254.